Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Nov;85(5):573-607.
doi: 10.1016/j.jinf.2022.08.016. Epub 2022 Aug 28.

Diagnostic value of serum KL-6 and IL-6 levels in critically ill patients with COVID-19-associated pneumonia

Si-Ho Kim  1 , Hyun Kyu Cho  2 , Chun-Hoo Jeon  1 , Hye Sung Ock  2 , Beomsu Shin  3 , Yu Mi Wi  4
Affiliations
Comment

Diagnostic value of serum KL-6 and IL-6 levels in critically ill patients with COVID-19-associated pneumonia

Si-Ho Kim et al. J Infect. 2022 Nov.
No abstract available

Keywords: COVID-19; Interleukin-6; Krebs von den lungen-6; Mortality; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare no conflicts of interest.

Figures

Fig 1:
Fig. 1
Difference between serum KL-6 and IL-6 levels measured at admission and one week after admission. (a) KL-6 KL‐6, Krebs von den Lungen‐6 *Serial data of KL-6 measurements from 25 to 65 deceased and survived patients, respectively. (b) IL-6 IL-6, interleukin-6 *Serial data of IL-6 measurements from 24 to 59 deceased and survived patients, respectively.
See this image and copyright information in PMC

Comment in

  • CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19.
    Gregersen I, Ueland T, Holter JC, Olsen MB, Michelsen AE, Murphy SL, Tveita AA, Henriksen KN, Hoel H, Nordberg LB, Holten AR, Edvardsen T, Yang K, Heggelund L, Trøseid M, Müller F, Kildal AB, Dyrhol-Riise AM, Barratt-Due A, Dahl TB, Aukrust P, Halvorsen B; NOR-SOLIDARITY consortium, The Norwegian SARS-CoV-2 Study Group investigators. Gregersen I, et al. J Infect. 2022 Dec;85(6):702-769. doi: 10.1016/j.jinf.2022.09.029. Epub 2022 Oct 8. J Infect. 2022. PMID: 36216188 Free PMC article. No abstract available.

Comment on

  • Interleukin-6 as prognosticator in patients with COVID-19.
    Grifoni E, Valoriani A, Cei F, Lamanna R, Gelli AMG, Ciambotti B, Vannucchi V, Moroni F, Pelagatti L, Tarquini R, Landini G, Vanni S, Masotti L. Grifoni E, et al. J Infect. 2020 Sep;81(3):452-482. doi: 10.1016/j.jinf.2020.06.008. Epub 2020 Jun 8. J Infect. 2020. PMID: 32526326 Free PMC article. No abstract available.

References

    1. Grifoni E., Valoriani A., Cei F., Lamanna R., Gelli A.M.G., Ciambotti B., et al. Interleukin-6 as prognosticator in patients with COVID-19. J Infect. 2020;81:452–482. - PMC - PubMed
    1. Siddiqi H.K., Mehra M.R. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020;39:405–407. - PMC - PubMed
    1. Choi M.G., Choi S.M., Lee J.H., Yoon J.K., Song J.W. Changes in blood Krebs von den Lungen-6 predict the mortality of patients with acute exacerbation of interstitial lung disease. Sci Rep. 2022;12:4916. - PMC - PubMed
    1. Coomes E.A., Haghbayan H. Interleukin-6 in Covid-19: a systematic review and meta-analysis. Rev Med Virol. 2020;30:1–9. - PMC - PubMed
    1. Kobayashi J., Kitamura S. KL-6: a serum marker for interstitial pneumonia. Chest. 1995;108:311–315. - PubMed